DFAS
Dimensional U.S. Small Cap ETF
DFAS actively invests in small-cap US companies, selected using multiple factors and weighted by market capitalization.
US
EQUITY
Active
MANAGEMENT STYLE
$ 15.2 B
ASSETS UNDER MGMT
26 bp
EXPENSES
Fund Basics
| Inception date | Jun 14, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SAPIENS INTERNATIONAL CORP | 8.5 % |
| ATARA BIOTHERAPEUTICS INC | 2.7 % |
| REGAL BELOIT CORP | 0.4 % |
| CRANE HOLDINGS, CO. | 0.4 % |
| AMKOR TECHNOLOGY INC | 0.3 % |
| RAMBUS INC | 0.3 % |
| TTM TECHNOLOGIES | 0.3 % |
| ADVANCED ENERGY INDUSTRIES | 0.3 % |
| MODINE MANUFACTURING CO | 0.3 % |
| WESCO INTERNATIONAL INC | 0.2 % |
Constituent Breakdown
| Number of holdings | 2128 |
| Herfindahl-Hirschman Index | 96 |
| Wgt avg mkt cap (mns) | $5,467 |
| Large cap (>$10bn) | 13.8% |
| Mid cap ($2-10bn) | 64.7% |
| Small cap (<$2bn) | 17.3% |
| Developed mkts. | 97.3% |
| Emerging mkts. | 0.1% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 85.6 % |
 |
ISRAEL | 8.5 % |
 |
BERMUDA | 1.0 % |
 |
BRITAIN | 0.6 % |
 |
IRELAND | 0.5 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 2.1% | 19.0% | 6.8% | 10.5% | -- | -- | -- | 4.0% |
| Dividend Yield | 0.2% | 1.3% | 1.1% | 1.2% | -- | -- | -- | 1.7% |
| Total Returns | 2.3% | 20.3% | 7.9% | 11.7% | -- | -- | -- | 5.7% | Ann. Volatility | 18.8% | 22.0% | 20.5% | 19.7% | -- | -- | -- | 21.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.01 | 76% |
| MSCI EAFE | 0.93 | 57% |
| MSCI Emg Mkts | 0.74 | 47% |
Liquidity Measures
| Avg. volume (000) | 496 |
| ADV traded (mns) | $38 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.03% |
Technical Indicators
| 30d moving avg. (EMA) | $74.30 |
| Relative strength (RSI) | 60 |
| MACD/Signal | 1.34/1.02 |
| Bollinger Bands (Upper/Lower) | $79.25/$69.14 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. DFAS |
Expenses vs. DFAS |
ALTAR Score™ vs. DFAS |
|---|---|---|---|---|
| ISCB | iShares Morningstar Small-Cap ETF | 62.8% | -22 bp | -0.2% |
| VTWO | Vanguard Russell 2000 ETF | 56.5% | -19 bp | -2.9% |
| SCHA | Schwab U.S. Small-Cap ETF | 54.7% | -22 bp | -1.2% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 52.9% | -9 bp | -0.6% |
| ISCV | iShares Morningstar Small Cap Value ETF | 51.5% | -20 bp | +2.1% |
| VXF | Vanguard Extended Market ETF | 51.4% | -21 bp | -1.7% |
| RSSL | Global X Russell 2000 ETF | 49.8% | -18 bp | -2.9% |
| VB | Vanguard Small-Cap ETF | 48.7% | -21 bp | -0.4% |
| IWM | iShares Russell 2000 ETF | 48.6% | -7 bp | -3.0% |
| VBR | Vanguard Small Cap Value ETF | 46.3% | -19 bp | +2.2% |
Risk and Returns: DFAS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/29/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.2%
ALTAR SCORE™
63rd
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. DFAS's ALTAR Score™ is approximately 0.3 standard
deviations above the category average. This places DFAS in the 63rd percentile
among funds in the category.
Sell-Side Consensus
$88.04
PRICE TARGET
+14.9%
UPSIDE